Moderna's Cancer Vaccine Breakthrough Meets a Wall Street Meltdown
Moderna shares plunged after details of its experimental cancer vaccine trial leaked ahead of a scheduled presentation, even though the results were positive.
More Videos
iPhone Duo: The Biggest Features, Biggest Risks And What Buyers Need To Know
Mark Spoonauer, Global Editor-in-Chief at Tom’s Guide, demos Apple’s iPhone Duo, breaking down its features, durability, pricing and preorder demand.
The Next AI Gold Rush? Inside the Race to Build Humanoid Robots
Andrew Kang, CEO of RoboStrategy, breaks down the robotics investment boom, humanoid AI, and the high-stakes race between the U.S. and China.
Tesla’s Flying Roadster, Robotaxis and SpaceX Merger Buzz: What Investors Need to Know
Seth Goldstein, Senior Equity Analyst at Morningstar, examines Tesla’s new Roadster, SpaceX merger speculation and the race to make robotaxis profitable.
The Future of Household Chores? This Startup Is Bringing Home Robots to the Masses
Antoine Marcel, founder and CEO of Flourish Robots, discusses how its AI-powered robot could transform household chores and bring home robotics to the masses.
Can You Put a Price on Fear? Inside the Economics of Halloween Attractions
Chris Stafford, haunted house expert and CEO of Thirteenth Floor Entertainment, reveals the business behind Halloween’s biggest scares and immersive attractions
Can a 145-Year-Old Watch Brand Win Over Gen Z? Movado’s CEO Reveals the Strategy
Efraim Grinberg, Chairman and CEO of Movado Group, discusses keeping iconic watch brands relevant, expanding its portfolio and reaching a new generation.
